Tamara Quint

Years Active: 2018-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas James Campion, Anna Doralt, Christian Lupinek, Markus Berger, Katharina Poglitsch, Jonas Brugger, Tamara Quint, Katharina Gangl, Christoph Sinz, Tina Bartosik, David Tianxiang Liu, Lukas David Landegger, Aldine Tu, Victoria Stanek, Uwe Berger, Christine Bangert, Sven Schneider, Julia Eckl-Dorna
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production. Allergy (2023)
Nicholas James Campion, Anna Doralt, Christian Lupinek, Markus Berger, Katharina Poglitsch, Jonas Brugger, Tamara Quint, Katharina Gangl, Christoph Sinz, Tina Bartosik, David Tianxiang Liu, Lukas David Landegger, Aldine Tu, Victoria Stanek, Uwe Berger, Christine Bangert, Sven Schneider, Julia Eckl-Dorna
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen-specific IgE production. Allergy (2023)
David Chromy, Tina Bartosik, Faris F Brkic, Tamara Quint, Aldine Tu, Julia Eckl-Dorna, Sven Schneider, Christine Bangert
Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis. The Journal of dermatology (2022)
Tamara Quint, Stefan Wöhrl, Tamar Kinaciyan
Fixed drug eruption caused by fluconazole-An underdiagnosed but recurrent problem. Contact dermatitis 80 (3) (2018)

Tamara Quint.css-eqlu8i{font-size:small;padding-left:4px;}